Background illustration for clinical trials search

Paid Clinical Trials Cambridge

Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

for
Adenovirus Infections
Location: Boston MA, New Hyde Park NY, Hackensack NJ, New York NY,
Sponsor: SymBio Pharmaceuticals

Sex: All

Age: 0+

Code: NCT07387367

Phase 3, Recruiting

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

for
Lung Cancer, Genetic Disease, Genetic Predisposition,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT05587439

Recruiting

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

for
Non-small Cell Lung Cancer, Advanced Pancreatic Adenocarcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04789486

Phase 1, Phase 2, Recruiting

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

for
Acute Myeloid Leukemia
Location: Boston MA, New York NY, Baltimore MD, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT06284486

Phase 1, Phase 2, Recruiting

Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer

for
Pancreatic Cancer
Location: Boston MA, Hartford CT, Charlottesville VA, Houston TX,
Sponsor: Craig L Slingluff, Jr

Sex: All

Age: 18+

Code: NCT02305186

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genetics of Neonatal Encephalopathy and Related Disorders

for
Neonatal Encephalopathy, Hypoxic Ischaemic Encephalopathy (HIE)
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0+

Code: NCT07165938

Recruiting

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

for
Lymphoma, Primary Central Nervous System Lymphoma
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06475235

Phase 1, Recruiting

Substrates for Post-Stroke Arm Rehabilitation

for
Stroke Rehabilitation, Stroke, Neurorecovery
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06998485

Recruiting

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Colorectal Cancer,
Location: Boston MA, New York NY, Syracuse NY, Philadelphia PA,
Sponsor: Merus B.V.

Sex: All

Age: 18+

Code: NCT03526835

Phase 1, Phase 2, Recruiting

Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study

for
Cancer Diagnosis
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 45+

Code: NCT06523868

Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Boston MA, New York NY, Sherbrooke, Montreal, Quebec,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07277231

Phase 3, Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Boston MA, Commack NY, Harrison NY, Uniondale NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06099769

Phase 2, Recruiting

Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

for
Endometrial Carcinoma, Obesity, EIN,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT04839614

Recruiting

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

for
Non-Hodgkin's Lymphoma, Hodgkin's Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT00131014

Recruiting

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

for
Depressive Symptoms, Urinary Incontinence, Sexual Dysfunction
Location: Wellesley MA, Toronto, Winter Garden FL
Sponsor: BTL Industries Ltd.

Sex: Female

Age: 40+

Code: NCT07413705

Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Boston MA, Lebanon NH, Lake Success NY, New York NY,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase 3, Recruiting

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

for
Sarcoma, Sarcoma, Ewing, Desmoplastic Small Round Cell Tumor,
Location: Boston MA
Sponsor: David S Shulman, MD

Sex: All

Age: 12 - 49

Code: NCT06709495

Phase 1, Phase 2, Recruiting

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

for
Severe Asthma
Location: Fall River MA, New York NY, Williamsburg VA,
Sponsor: Generate Biomedicines

Sex: All

Age: 12 - 70+

Code: NCT07359846

Phase 3, Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

for
Solid Tumors With HRAS Alterations,
Location: Boston MA, New Brunswick NJ, Pittsburgh PA, Detroit MI,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06026410

Phase 1, Recruiting

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Boston MA, Beverly MA, Portsmouth NH, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06585410

Phase 3, Recruiting